In the current meta-analysis, 15 case-control studies involving 2429 PCOS patients and 2050 control women were included to estimate the relationship between the CYP17A1 (rs743572) polymorphisms and PCOS risk. This evidence concerns the gene CYP17A1 and polycystic ovary syndrome.